Stockscreener 앱 받기
41.50
1.17%
-0.49
전일 마감가:
$41.99
열려 있는:
$42.65
하루 거래량:
894.22K
Relative Volume:
2.53
시가총액:
$744.40M
수익:
$116.88M
순이익/손실:
$-25.09M
주가수익비율:
-296.43
EPS:
-0.14
순현금흐름:
$-20.74M
1주 성능:
+5.04%
1개월 성능:
+106.88%
6개월 성능:
+106.57%
1년 성능:
+243.26%
1일 변동 폭
$41.00
$43.72
1주일 범위
$38.43
$43.72
52주 변동 폭
$12.00
$43.72
Rigel Pharmaceuticals Stock (RIGL) Company Profile
명칭
Rigel Pharmaceuticals
전화
650-624-1100
주소
611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA
RIGL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RIGL
Rigel Pharmaceuticals
|
41.50 | 718.75M | 116.88M | -25.09M | -20.74M | -0.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-04-03 | 재개 | Piper Sandler | Neutral |
| 2022-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-06-08 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-03-23 | 개시 | B. Riley Securities | Neutral |
| 2020-11-09 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-11-15 | 재개 | Cantor Fitzgerald | Overweight |
| 2019-09-26 | 재개 | JP Morgan | Overweight |
| 2019-03-01 | 재확인 | Cantor Fitzgerald | Overweight |
| 2018-08-27 | 개시 | Citigroup | Buy |
| 2018-05-02 | 재확인 | Cantor Fitzgerald | Overweight |
| 2017-12-21 | 재개 | Piper Jaffray | Overweight |
| 2017-12-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-11-06 | 재개 | H.C. Wainwright | Buy |
| 2017-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-31 | 재확인 | H.C. Wainwright | Buy |
| 2016-08-30 | 재확인 | Piper Jaffray | Overweight |
| 2016-07-13 | 개시 | H.C. Wainwright | Buy |
| 2016-06-13 | 개시 | Piper Jaffray | Overweight |
| 2016-04-22 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2013-04-08 | 재확인 | Stifel | Buy |
| 2012-11-29 | 개시 | UBS | Neutral |
| 2012-11-06 | 재확인 | Oppenheimer | Outperform |
| 2012-03-26 | 개시 | Canaccord Genuity | Hold |
| 2010-12-10 | 다운그레이드 | MP Advisors | Outperform → Market Perform |
모두보기
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
Rigel Pharma’s Comeback: Profits, Pipeline Progress, And A Bargain Price - Finimize
Watch for Bullish Crossover in Rigel Pharmaceuticals Inc.2025 Price Action Summary & Weekly Return Optimization Plans - newsyoung.net
Published on: 2025-08-16 07:20:24 - Newser
Key metrics from Rigel Pharmaceuticals Inc.’s quarterly data2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Is Rigel Pharmaceuticals Inc. a candidate for recovery playJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - Newser
Published on: 2025-08-16 02:21:32 - Newser
Automated trading signals detected on Rigel Pharmaceuticals Inc.CPI Data & Weekly Breakout Watchlists - Newser
What indicators show strength in Rigel Pharmaceuticals Inc.Trade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Will a bounce in Rigel Pharmaceuticals Inc. offer an exitJuly 2025 Pullbacks & Expert Verified Movement Alerts - Newser
Has Rigel Pharmaceuticals Inc. found a price floorExit Point & Daily Stock Trend Reports - Newser
Sector ETF performance correlation with Rigel Pharmaceuticals Inc.2025 Dividend Review & Community Consensus Trade Signals - Newser
Forecasting Rigel Pharmaceuticals Inc. price range with options data2025 AllTime Highs & Daily Chart Pattern Signals - Newser
What are Rigel Pharmaceuticals Inc.’s recent SEC filings showingMarket Growth Review & Weekly Stock Breakout Alerts - newsimpact.co.kr
Can volume confirm reversal in Rigel Pharmaceuticals Inc.July 2025 Movers & Safe Capital Investment Plans - Newser
Published on: 2025-08-15 05:51:08 - sundaytimes.kr
Warm Autoimmune Hemolytic Anemia Market to Observe Significant Growth During the Forecast Period | Rigel Pharmaceuticals, Apellis Pharmaceuticals, Inc., Johnson & Johnson, Sanofi, Incyte Corporation - Barchart.com
Rigel Pharmaceuticals Inc. Recovery Linked to Earnings SurprisePortfolio Update Summary & Free Growth Oriented Trading Recommendations - classian.co.kr
Rigel Pharmaceuticals Q2 Earnings Boost Breakout Potential - AInvest
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha
Rigel Pharmaceuticals (RIGL) up more than 100% since Jul 18 - AInvest
Using Python tools to backtest Rigel Pharmaceuticals Inc. strategiesJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Rigel Pharmaceuticals' Earnings Mask Underlying Cash Flow Concerns - AInvest
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance
Technical signs of recovery in Rigel Pharmaceuticals Inc.Oversold Stock Bounce Playbook Generator - Newser
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Insider Monkey
RIPK1 Inhibitor Pipeline Outlook Report 2025: Key 10+ Companies and Breakthrough Therapies Shaping the Future Landscape - The Globe and Mail
Best Momentum Stock to Buy for August 8th - MSN
Rigel targets up to $280M 2025 revenue as IRA boosts sales and pipeline advances - MSN
Cantor Fitzgerald Analysts Boost Earnings Estimates for RIGL - Defense World
HC Wainwright Issues Positive Estimate for RIGL Earnings - Defense World
Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? - Yahoo Finance
Top 5 Stocks with Strong Price Performance to Buy Now - AInvest
5 Best Stocks With Relative Price Strength to Buy Right Now - sg.finance.yahoo.com
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
New Strong Buy Stocks for August 8th - TradingView
Rigel Pharmaceuticals reports Q2 EPS $3.91, consensus $1.40 - MSN
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2025 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals Flips To A Profit On Rising Sales - Finimize
Jefferies Reaffirms Their Hold Rating on Rigel (RIGL) - The Globe and Mail
Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Citi Analysts Maintain Buy Rating on Rigel with $67 Price Target - AInvest
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates - MSN
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth - TipRanks
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $67 - 富途牛牛
Rigel Pharmaceuticals (NASDAQ:RIGL) Shareholder Returns Have Been Solid, Earning 160% in 1 Year - 富途牛牛
Cantor Fitzgerald Raises Price Target for RIGL to $32.00, Mainta - GuruFocus
Rigel Pharmaceuticals shares surge 16.67% intraday after strong Q2 earnings and revenue guidance. - AInvest
Rigel Pharmaceuticals: Cantor Fitzgerald Maintains Neutral, PT Raised to $32 from $23. - AInvest
Rigel Pharmaceuticals (RIGL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rigel Pharmaceuticals 주식 (RIGL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Schorno Dean L | EVP & Chief Financial Officer |
Feb 05 '25 |
Sale |
21.93 |
1,734 |
38,020 |
57,235 |
| Santos David A | EVP, Chief Commercial Officer |
Feb 04 '25 |
Sale |
20.92 |
2,125 |
44,457 |
53,500 |
| Santos David A | EVP, Chief Commercial Officer |
Feb 05 '25 |
Sale |
21.93 |
1,796 |
39,379 |
51,704 |
| RODRIGUEZ RAUL R | CEO, President |
Feb 04 '25 |
Sale |
20.92 |
4,952 |
103,601 |
243,854 |
| RODRIGUEZ RAUL R | CEO, President |
Feb 05 '25 |
Sale |
21.93 |
4,400 |
96,474 |
239,454 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec |
Feb 04 '25 |
Sale |
20.92 |
1,448 |
30,294 |
40,169 |
| Furey Raymond J. | EVP, GC, CCO & Corp Sec |
Feb 05 '25 |
Sale |
21.93 |
1,339 |
29,359 |
38,830 |
0.94%
1.72%
자본화:
|
볼륨(24시간):